| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3988488 | European Journal of Surgical Oncology (EJSO) | 2006 | 6 Pages |
Abstract
AimsTo report clinical outcomes of a large series of cases with advanced thyroid cancer.Study designThree hundred and eighty-five patients at the UICC stages III and IV were selected for the study with thyroid cancer.ResultsPapillary carcinoma and sclerosing carcinoma have better survival than the Hürthle cell and insular types. Lymphatic metastasis does not appear to worsen the prognosis. All the tumour forms offer the chance of long survival.ConclusionsSurgical treatment is the primary treatment of thyroid carcinoma. The combined treatments of surgery, metabolic beam therapy, suppressive hormone therapy, radiotherapy and chemotherapy cure a high percentage of patients with the tumour at an advanced stage.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
G. Freschi, L. Landi, A. Castagnoli, A. Taddei, P. Bechi, G. Bucciarelli,